421 related articles for article (PubMed ID: 26790955)
1. Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.
Li P; Guo Y; Bledsoe G; Yang Z; Chao L; Chao J
Exp Cell Res; 2016 Jan; 340(2):305-14. PubMed ID: 26790955
[TBL] [Abstract][Full Text] [Related]
2. Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression.
Chao J; Guo Y; Li P; Chao L
Oxid Med Cell Longev; 2017; 2017():5025610. PubMed ID: 28744338
[TBL] [Abstract][Full Text] [Related]
3. Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.
Guo Y; Li P; Bledsoe G; Yang ZR; Chao L; Chao J
Exp Cell Res; 2015 Sep; 337(1):103-10. PubMed ID: 26156753
[TBL] [Abstract][Full Text] [Related]
4. Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress.
Chao J; Li P; Chao L
Biol Chem; 2017 Nov; 398(12):1309-1317. PubMed ID: 28742513
[TBL] [Abstract][Full Text] [Related]
5. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.
Guo Y; Li P; Gao L; Zhang J; Yang Z; Bledsoe G; Chang E; Chao L; Chao J
Aging Cell; 2017 Aug; 16(4):837-846. PubMed ID: 28544111
[TBL] [Abstract][Full Text] [Related]
6. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6.
Zhang J; Yang Z; Li P; Bledsoe G; Chao L; Chao J
Mol Cell Biochem; 2013 Jul; 379(1-2):295-301. PubMed ID: 23666756
[TBL] [Abstract][Full Text] [Related]
7. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
[TBL] [Abstract][Full Text] [Related]
8. Kallistatin suppresses cancer development by multi-factorial actions.
Chao J; Li P; Chao L
Crit Rev Oncol Hematol; 2017 May; 113():71-78. PubMed ID: 28427524
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
10. Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation.
Chao J; Guo Y; Chao L
Oxid Med Cell Longev; 2018; 2018():4138560. PubMed ID: 30622668
[TBL] [Abstract][Full Text] [Related]
11. Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway.
Guo Y; Chao L; Chao J
J Cell Mol Med; 2018 Sep; 22(9):4387-4398. PubMed ID: 29992759
[TBL] [Abstract][Full Text] [Related]
12. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
14. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
[TBL] [Abstract][Full Text] [Related]
15. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
16. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
17. Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.
Gao L; Li P; Zhang J; Hagiwara M; Shen B; Bledsoe G; Chang E; Chao L; Chao J
J Am Heart Assoc; 2014 Sep; 3(5):e001194. PubMed ID: 25237049
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.
Chen WY; Liu SY; Chang YS; Yin JJ; Yeh HL; Mouhieddine TH; Hadadeh O; Abou-Kheir W; Liu YN
Oncotarget; 2015 Jan; 6(1):441-57. PubMed ID: 25436980
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
Guan H; Liu C; Fang F; Huang Y; Tao T; Ling Z; You Z; Han X; Chen S; Xu B; Chen M
Oncotarget; 2017 Feb; 8(9):14693-14707. PubMed ID: 28107193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]